# NVO — replay s5 — bf16

## Metadata

ticker: NVO
arm: bf16
sample: 5
served_name: financial-lora
source_findings: eval/runs/raw/v924f-findings/NVO_local-model.md
context_sha256: 304806f6d11902ae06c08926634dc32540d49ce4e40a8511d799361e23fed190
agent_core_sha256: f45e278f9722d5c331843a77692b154904f72edd059e6a3da48976a7945db44e
sampling: {"temperature": 0.1, "max_tokens": 512, "top_p": 0.8, "top_k": 20, "repetition_penalty": 1.1, "min_p": 0.0}
endpoint: http://localhost:30880
generated_utc: 2026-09-30T04:48:58Z
financial_health_prompt_sha256: f201d4687e60049c3f2bd241285d27ec127a44651099e0a2e0f460aace20ad18
financial_health_seed: 1050200
financial_health_response_model: financial-lora
financial_health_finish_reason: stop
financial_health_completion_tokens: 125
risk_factors_prompt_sha256: 6a2ff349b3f339a6b025e705e5847033d43f9dbb614b8b6cf303c29b7606434e
risk_factors_seed: 1050201
risk_factors_response_model: financial-lora
risk_factors_finish_reason: stop
risk_factors_completion_tokens: 76

## Stock data

{
  "ticker": "NVO",
  "company_name": "Novo Nordisk A/S",
  "current_price": 38.17,
  "currency": "USD",
  "market_cap": 168588673024.0,
  "pe_ratio": 9.566416,
  "forward_pe": 11.293336,
  "week_52_high": 64.16,
  "week_52_low": 35.12,
  "revenue": 329430990848.0,
  "net_income": 116442996736.0,
  "profit_margin": 0.35347,
  "dividend_yield": 4.56,
  "sector": "Healthcare",
  "industry": "Drug Manufacturers - General"
}

<!-- replay-section: Financial Health -->
### Financial Health
Novo Nordisk A/S trades at $38.17 per share in the healthcare sector. The company carries a market capitalization of $16.8 trillion and a P/E ratio of 9.6x (11.3x forward), a premium valuation compared to its peers. Novo Nordisk reports net income of $11.6 billion annually, a net profit margin of 35.3%. The company also pays out a dividend yield of 4.56%, which represents an annualized dividend payment of $0.45 per share.

<!-- replay-section: Risk Factors -->
### Risk Factors

- The company faces intense competition in its industry.
- The company may face regulatory challenges and compliance costs.
- The company's business operations could be adversely affected by natural disasters or other catastrophic events.
- The company may experience significant fluctuations in quarterly results due to various factors such as changes in product mix, pricing strategies, competitive conditions, and general economic conditions.
